Gebremedhin B. Gebretekle
Zambia Street
Addis Ababa, AA, Ethiopia
Addis Ababa, AA, Ethiopia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool.
Journal: Behavior research methods
Published: June 14, 2025
Cost-Utility Analysis of COVID-19 Vaccination Strategies for Endemic SARS-CoV-2.
Journal: JAMA network open
Published: June 13, 2025
Economic analysis of 15-valent and 20-valent pneumococcal conjugate vaccines among older adults in Ontario, Canada.
Journal: Expert review of vaccines
Published: April 03, 2025
Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison.
Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: February 24, 2025
Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis.
Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: February 21, 2025
Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations.
Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: February 21, 2025
Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada.
Journal: Vaccine
Published: October 28, 2024
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: June 11, 2024
The psychometric properties of the amharic version of EuroQoL five-dimensions-five level among Ethiopian cervical cancer patients.
Journal: Health and quality of life outcomes
Published: June 06, 2024
Treatment outcomes of standardized injectable shorter regimen for multi-drugs resistant tuberculosis in Ethiopia: a retrospective cohort study.
Journal: BMC infectious diseases
Published: May 21, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.
Journal: Vaccine
Published: March 26, 2024
Last Updated: 09/26/2026